The FDA Has Fast-Tracked A First-Of-Its Kind Cancer Treatment

This unique drug targets tumors based off of genetic information.

June 12, 2017

An Affordable Version of the EpiPen Is Now Available

It's over 80% cheaper and is available to purchase today.

January 13, 2017

Bringing CRISPR to Market: CRISPR Therapeutics Partners with Bayer in $300M Joint Venture

CRISPR patent holder CRISPR Therapeutics AG joins pharmaceutical giant Bayer in a $300 million joint venture to develop drugs for blood disorders, blindness, and heart disease.

December 27, 2015
Subscribe
Like us on Facebook